IBDEI100 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17794,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17794,1,2,0)
 ;;=2^295.70
 ;;^UTILITY(U,$J,358.3,17794,1,5,0)
 ;;=5^Schizoaffective Disorder NOS
 ;;^UTILITY(U,$J,358.3,17794,2)
 ;;=^331857
 ;;^UTILITY(U,$J,358.3,17795,0)
 ;;=295.90^^95^1001^13
 ;;^UTILITY(U,$J,358.3,17795,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17795,1,2,0)
 ;;=2^295.90
 ;;^UTILITY(U,$J,358.3,17795,1,5,0)
 ;;=5^Schizophrenia NOS,Unspec
 ;;^UTILITY(U,$J,358.3,17795,2)
 ;;=^108287
 ;;^UTILITY(U,$J,358.3,17796,0)
 ;;=300.11^^95^1002^1
 ;;^UTILITY(U,$J,358.3,17796,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17796,1,2,0)
 ;;=2^300.11
 ;;^UTILITY(U,$J,358.3,17796,1,5,0)
 ;;=5^Conversion Disorder
 ;;^UTILITY(U,$J,358.3,17796,2)
 ;;=^28139
 ;;^UTILITY(U,$J,358.3,17797,0)
 ;;=300.7^^95^1002^2
 ;;^UTILITY(U,$J,358.3,17797,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17797,1,2,0)
 ;;=2^300.7
 ;;^UTILITY(U,$J,358.3,17797,1,5,0)
 ;;=5^Hyponchondriasis
 ;;^UTILITY(U,$J,358.3,17797,2)
 ;;=^60556
 ;;^UTILITY(U,$J,358.3,17798,0)
 ;;=300.81^^95^1002^3
 ;;^UTILITY(U,$J,358.3,17798,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17798,1,2,0)
 ;;=2^300.81
 ;;^UTILITY(U,$J,358.3,17798,1,5,0)
 ;;=5^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,17798,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,17799,0)
 ;;=307.1^^95^1003^1
 ;;^UTILITY(U,$J,358.3,17799,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17799,1,2,0)
 ;;=2^307.1
 ;;^UTILITY(U,$J,358.3,17799,1,5,0)
 ;;=5^Anorexia Nervosa
 ;;^UTILITY(U,$J,358.3,17799,2)
 ;;=^7942
 ;;^UTILITY(U,$J,358.3,17800,0)
 ;;=307.51^^95^1003^2
 ;;^UTILITY(U,$J,358.3,17800,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17800,1,2,0)
 ;;=2^307.51
 ;;^UTILITY(U,$J,358.3,17800,1,5,0)
 ;;=5^Bulemia
 ;;^UTILITY(U,$J,358.3,17800,2)
 ;;=^17407
 ;;^UTILITY(U,$J,358.3,17801,0)
 ;;=307.50^^95^1003^3
 ;;^UTILITY(U,$J,358.3,17801,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17801,1,2,0)
 ;;=2^307.50
 ;;^UTILITY(U,$J,358.3,17801,1,5,0)
 ;;=5^Eating Disorder, NOS
 ;;^UTILITY(U,$J,358.3,17801,2)
 ;;=^37864
 ;;^UTILITY(U,$J,358.3,17802,0)
 ;;=333.99^^95^1004^1
 ;;^UTILITY(U,$J,358.3,17802,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17802,1,2,0)
 ;;=2^333.99
 ;;^UTILITY(U,$J,358.3,17802,1,5,0)
 ;;=5^Acute Akathisia
 ;;^UTILITY(U,$J,358.3,17802,2)
 ;;=^303698
 ;;^UTILITY(U,$J,358.3,17803,0)
 ;;=332.0^^95^1004^3
 ;;^UTILITY(U,$J,358.3,17803,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17803,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,17803,1,5,0)
 ;;=5^Parkinsonism
 ;;^UTILITY(U,$J,358.3,17803,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,17804,0)
 ;;=333.79^^95^1004^2
 ;;^UTILITY(U,$J,358.3,17804,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17804,1,2,0)
 ;;=2^333.79
 ;;^UTILITY(U,$J,358.3,17804,1,5,0)
 ;;=5^Acute Dystonia
 ;;^UTILITY(U,$J,358.3,17804,2)
 ;;=^334068
 ;;^UTILITY(U,$J,358.3,17805,0)
 ;;=333.85^^95^1004^4
 ;;^UTILITY(U,$J,358.3,17805,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17805,1,2,0)
 ;;=2^333.85
 ;;^UTILITY(U,$J,358.3,17805,1,5,0)
 ;;=5^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,17805,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,17806,0)
 ;;=V87.39^^95^1005^1
 ;;^UTILITY(U,$J,358.3,17806,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17806,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,17806,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,17806,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,17807,0)
 ;;=310.0^^95^1006^2
 ;;^UTILITY(U,$J,358.3,17807,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17807,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,17807,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,17807,2)
 ;;=^265201
